Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Covington
McKesson
McKinsey
Merck
Argus Health
Express Scripts
Teva
Boehringer Ingelheim

Generated: May 21, 2018

DrugPatentWatch Database Preview

Aspirin; dipyridamole - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for aspirin; dipyridamole and what is the scope of aspirin; dipyridamole patent protection?

Aspirin; dipyridamole
is the generic ingredient in two branded drugs marketed by Boehringer Ingelheim, Amneal Pharms, Barr, Impax Labs Inc, Par Pharm Inc, Sandoz Inc, and Zydus Pharms Usa Inc, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for aspirin; dipyridamole. Thirteen suppliers are listed for this compound.
Synonyms for aspirin; dipyridamole
2-acetyloxybenzoic acid; 2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol
87653-67-6
AC1L3AE0
Aggrenox
Asasantin
Asasantin Retard
Aspirin / Dipyridamole
Aspirin mixture with Dipyridamole
aspirin, dipyridamole drug combination
Aspirin/extended-release dipyridamole
Benzoic acid, 2-(acetyloxy)-, mixt. with 2,2',2'',2'''-((4,8-di-1-piperidinylpyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis(ethanol)
C24H40N8O4.C9H8O4
D0F3IP
DTXSID40236543
HE400521
LS-178622
SCHEMBL456521
TX 3301
TX-3301

US Patents and Regulatory Information for aspirin; dipyridamole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 078804-001 Aug 14, 2009 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim AGGRENOX aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 020884-001 Nov 22, 1999 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Impax Labs Inc ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 206964-001 Jan 18, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 206753-001 Aug 29, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Accenture
UBS
Healthtrust
Farmers Insurance
McKinsey
Harvard Business School
US Department of Justice
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.